Clinical Trial Update: Study Evaluating the Safety and Efficacy of Islatravir in Combination With Lenacapavir in Virologically Suppressed People With HIV [Phase 2]

View source ↗

Summary

A Phase 2 study assessing the safety and efficacy of the two-drug combination of islatravir and lenacapavir in virologically suppressed people with HIV; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Islatravir (Islatravir)
• Lenacapavir (lenacapavir)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV-1 Infection | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-01-14